![Eric Burak](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric Burak
Chief Tech/Sci/R&D Officer at
FUSN PHAR
Profile
Eric Burak currently works at Fusion Pharmaceuticals, Inc., as Chief Technology Officer from 2021.
Dr. Burak also formerly worked at Guilford Pharmaceuticals, Inc., as Director-Drug Metabolism & Pharmacokinetics, Melinta Subsidiary Corp., as Vice President-Advanced Preclinical Development, Theracos, Inc., as Vice President-Development from 2011 to 2012, and Centre For Probe Development & Commercialization, as Chief Scientific Officer from 2012 to 2017.
Dr. Burak received his undergraduate degree from Drexel University and doctorate degree from Temple University (Pennsylvania).
Eric Burak active positions
| Companies | Position | Start |
|---|---|---|
| FUSN PHAR | Chief Tech/Sci/R&D Officer | 2017-01-31 |
Former positions of Eric Burak
| Companies | Position | End |
|---|---|---|
Centre For Probe Development & Commercialization
 Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes radiopharmaceuticals for early diagnosis and treatment of diseases | Chief Tech/Sci/R&D Officer | 2017-01-31 |
Theracos, Inc.
 Theracos, Inc. BiotechnologyHealth Technology Develops novel therapeutics for diseases | Corporate Officer/Principal | 2012-09-30 |
Guilford Pharmaceuticals, Inc.
 Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs used to treat neurological diseases | Corporate Officer/Principal | - |
Melinta Subsidiary Corp.
 Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for the treatment of life-threatening infections | Corporate Officer/Principal | - |
Training of Eric Burak
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
3
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Guilford Pharmaceuticals, Inc.
Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs used to treat neurological diseases | Health Technology |
Drexel University
 Drexel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Temple University (Pennsylvania)
 Temple University (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Melinta Subsidiary Corp.
Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for the treatment of life-threatening infections | Health Technology |
Theracos, Inc.
Theracos, Inc. BiotechnologyHealth Technology Develops novel therapeutics for diseases | Health Technology |
Fusion Pharmaceuticals, Inc.
 Fusion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company developing next-generation radiopharmaceuticals for the treatment of cancer | Health Technology |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes radiopharmaceuticals for early diagnosis and treatment of diseases | Health Technology |
- Stock Market
- Insiders
- Eric Burak
